MedTrace Logo

Effects of Limicol on LDL-cholesterol

NCT01354327 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2011-05-16

No results posted yet for this study

Summary

The principal objective of this study is to investigate the effects of a novel food supplement (Limicol) on LDL-cholesterol levels in healthy subjects with moderate hypercholesterolemia.

Conditions

  • Hypercholesteremia

Interventions

DIETARY_SUPPLEMENT

Limicol

3 tablets / day during 4 months

DIETARY_SUPPLEMENT

Placebo

3 tablets / day during 4 months

Sponsors & Collaborators

  • CIC Hôpital de la Conception - Marseille

    collaborator UNKNOWN

  • Aix Marseille Université

    collaborator OTHER

  • Lescuyer Laboratory

    lead INDUSTRY

Principal Investigators

  • Sébastien Peltier, PhD · Lescuyer Laboratory

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01354327 on ClinicalTrials.gov